logo_grayRensselaer Polytechnic Institute

title

Contents

Link to mobile version

Through a broad network of research centers, Rensselaer researchers are creating new routes to drug discovery and development, understanding the fundamental mechanisms of disease, as well as examining mechanisms for enabling affordable health care technologies and improving human health.

Therapeutic Intervention in Alzheimer’s Research
Rensselaer researchers have followed the trail of two genetic mutations to uncover how they lead to biochemical changes that are associated with Familial Alzheimer's, while a researcher in the LRC has used lighting to help seniors avoid falls during the night. Full Story

Drug Discovery and High-Throughput Screening
A team of researchers has developed a type of biochip that could enable pharmaceutical companies to start doing quick, reliable, high-throughput toxicity testing significantly earlier in the process of the testing of drug candidates. Full Story

Regenerative Medicine
Research is being carried out on developing new surgical tools and techniques for cutting and drilling bone that take into account both the age of individual patients as well as the particular microstructure of their bone will lead to faster recovery times and fewer revision surgeries for patients. Full Story

Biomanufacturing: Synthetic Heparin
Researchers have created a synthetic form of low-molecular-weight heparin that can be reversed in cases of overdose and would be safer for patients with poor kidney function. Full Story

Antimicrobial Research: Fighting Toxins and Pathogens
A new protein engineering technique developed at Rensselaer gives researchers a powerful new tool for fighting potentially harmful toxins and pathogens. Full Story

Partnerships in Health Care
Partnerships with Optum Labs and the Icahn School of Medicine at Mount Sinai are driving discoveries and innovations in health care at Rensselaer. Full Story

Medicine/Health Media Highlights